Rukobia (fostemsavir) is a brand-name extended-release (ER) oral tablet that’s prescribed for HIV in certain adults. If you have problems with side effects from Rukobia, talk with your doctor or ...

Only one attachment inhibitor, known as fostemsavir (Rukobia), is currently available. The FDA approved this drug in July 2020, making it one of the newest HIV drugs on the market. Rukobia is used ...

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HIV sales rose 14% driven by strong demand and ... Juluca rose 10% while Dovato was up 27% in the quarter. Rukobia sales rose 46% in the quarter. Sales of new long-acting medicines, Cabenuva ...

Acidre, who represents the Tingog party-list, said the 95-percent increase is expected to encourage more people living with HIV to seek treatment and motivate others to undergo regular testing.

It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government resources for HIV support at the time in Mexico, Lopez joined advocacy ...

1:52 6 million people could die from HIV, AIDS amid USAID funding freeze, UN warns A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing ...